# Post-transcriptional regulation of aromatic amino acid metabolism by GcvB small RNA in Escherichia coli

**Authors:** Takeshi Kanda, Toshiko Sekijima, Masatoshi Miyakoshi

PMC · DOI: 10.1128/spectrum.02035-24 · Microbiology Spectrum · 2025-01-27

## TL;DR

This paper explores how GcvB small RNA regulates aromatic amino acid metabolism in E. coli, identifying new target genes and mechanisms.

## Contribution

The study identifies new GcvB target genes in AAA biosynthesis and transport and reveals a direct base pairing mechanism for aroG repression.

## Key findings

- GcvB represses new target genes in AAA biosynthesis and transport via the R1 seed region.
- GcvB directly inhibits aroG expression through base pairing with the R3 seed sequence.
- GcvB overexpression affects growth and antibiotic resistance by regulating AAA transporters.

## Abstract

Escherichia coli synthesizes aromatic amino acids (AAAs) through the common pathway to produce the precursor, chorismate, and the three terminal pathways to convert chorismate into Phe, Tyr, and Trp. E. coli also imports exogenous AAAs through five transporters. GcvB small RNA post-transcriptionally regulates more than 50 genes involved in amino acid uptake and biosynthesis in E. coli, but the full extent of GcvB regulon is still underestimated. This study examined all genes involved in AAA biosynthesis and transport using translation reporter assay and qRT-PCR analysis. In addition to previously verified targets, aroC, aroP, and trpE, we identified new target genes that were significantly repressed by GcvB primarily via the R1 seed region. Exceptionally, GcvB strongly inhibits the expression of aroG, which encodes the major isozyme of the first reaction in the common pathway, through direct base pairing between the aroG translation initiation region and the GcvB R3 seed sequence. RNase E mediates the degradation of target mRNAs except aroC and aroP via its C-terminal domain. GcvB overexpression prolongs the lag phase and reduces the growth rate in minimal media supplemented with AAAs and confers resistance to an antibiotic compound, azaserine, by repressing AAA transporters.

E. coli strains have been genetically modified in relevant transcription factors and biosynthetic enzymes for industrial use in the fermentative production of aromatic amino acids (AAAs) and their derivative compounds. This study focuses on GcvB small RNA, a global regulator of amino acid metabolism in E. coli, and identifies new GcvB targets involved in AAA biosynthesis and uptake. GcvB represses the expression of the first and last enzymes of the common pathway and the first enzymes of Trp and Phe terminal pathways. GcvB also limits import of AAAs. This paper documents the impact of RNA-mediated regulation on AAA metabolism in E. coli.

## Linked entities

- **Genes:** gcvB (glycine dehydrogenase) [NCBI Gene 885716], aroC (chorismate synthase) [NCBI Gene 879481], aroP (phenylalanine transporter) [NCBI Gene 913640], trpE (anthranilate synthase component I) [NCBI Gene 879191], aroG (3-deoxy-7-phosphoheptulonate synthase) [NCBI Gene 884735]
- **Chemicals:** azaserine (PubChem CID 460129)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** aroG [NCBI Gene 20492795]
- **Species:** Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11878033/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11878033/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC11878033/full.md

---
Source: https://tomesphere.com/paper/PMC11878033